SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+13.27%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$437M
AUM Growth
+$437M
(+13%)
Cap. Flow
-$5.43M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
60.21%
Holding
38
New
7
Increased
8
Reduced
12
Closed
7
Top Buys
| 1 |
Labcorp
LH
|
$17.5M |
| 2 |
Edwards Lifesciences
EW
|
$13M |
| 3 |
Illumina
ILMN
|
$9.6M |
| 4 |
Tenet Healthcare
THC
|
$9.56M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$4.7M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$24.6M |
| 2 |
Biogen
BIIB
|
$11.1M |
| 3 |
Cigna
CI
|
$9.37M |
| 4 |
Merck
MRK
|
$5.98M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$4.53M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $51.2M | 11.7% | 596,036 -287,070 | -33% | -$24.6M |
|
2
Incyte
INCY
$16.5B
| $33.1M | 7.56% | 411,487 -7,307 | -2% | -$587K |
|
3
Cardinal Health
CAH
$35.5B
| $27.2M | 6.22% | 353,872 -4,828 | -1% | -$371K |
|
4
Bristol-Myers Squibb
BMY
$96B
| $27.2M | 6.21% | 377,669 +24,042 | +7% | +$1.73M |
|
5
Elevance Health
ELV
$71.8B
| $24.5M | 5.6% | 47,777 +1,745 | +4% | +$895K |
|
|
6
Merck
MRK
$210B
| $22.1M | 5.06% | 199,300 -53,859 | -21% | -$5.98M |
|
7
Medtronic
MDT
$119B
| $21.6M | 4.93% | 277,435 +7,478 | +3% | +$581K |
|
8
Zimmer Biomet
ZBH
$21B
| $19.6M | 4.49% | 154,116 -11,964 | -7% | -$1.53M |
|
|
9
Biogen
BIIB
$19.4B
| $19.4M | 4.43% | 70,039 -40,191 | -36% | -$11.1M |
|
|
10
Labcorp
LH
$23.1B
| $17.5M | 4.01% | +74,496 | New | +$17.5M |
|
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $16M | 3.67% | 155,009 +45,405 | +41% | +$4.7M |
|
12
Centene
CNC
$14.3B
| $15.2M | 3.47% | 184,901 -16,654 | -8% | -$1.37M |
|
|
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.6M | 3.12% | 106,207 +21,477 | +25% | +$2.76M |
|
14
Boston Scientific
BSX
$156B
| $13.6M | 3.12% | 294,784 -92,400 | -24% | -$4.28M |
|
15
Bruker
BRKR
$5.16B
| $13.1M | 3% | 191,982 -45,976 | -19% | -$3.14M |
|
|
16
Edwards Lifesciences
EW
$47.8B
| $13M | 2.97% | +174,252 | New | +$13M |
|
17
Qiagen
QGEN
$10.1B
| $11.6M | 2.66% | 233,473 +29,399 | +14% | +$1.47M |
|
18
Baxter International
BAX
$12.7B
| $11.3M | 2.58% | 221,088 +52,060 | +31% | +$2.65M |
|
|
19
Illumina
ILMN
$15.8B
| $9.6M | 2.2% | +47,500 | New | +$9.6M |
|
|
20
Tenet Healthcare
THC
$16.3B
| $9.56M | 2.19% | +195,954 | New | +$9.56M |
|
|
21
Cigna
CI
$80.3B
| $7.37M | 1.69% | 22,252 -28,265 | -56% | -$9.37M |
|
|
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
| $7.17M | 1.64% | 173,842 -74,807 | -30% | -$3.09M |
|
23
Bio-Rad Laboratories Class A
BIO
$8.06B
| $6.72M | 1.54% | 15,988 +4,000 | +33% | +$1.68M |
|
24
Ionis Pharmaceuticals
IONS
$6.79B
| $5.34M | 1.22% | 141,373 -22,850 | -14% | -$863K |
|
25
CVS Health
CVS
$92.8B
| $4.05M | 0.93% | 43,443 | – | – |
|